Pfizer Limited

The Capital, 1802/1901,

Plot No. C - 70, G Block, Bandra Kurla Complex,

Bandra (East), Mumbai 400 051.

Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 17, 2024

The Corporate Relationship Dept.

The Manager, Listing Dept.

BSE Limited

The National Stock Exchange of India Ltd.

1st Floor, P.J.Towers

Exchange Plaza, 5th Floor, Plot No. C/1,

Dalal Street, Fort

G Block Bandra-Kurla Complex, Bandra (E)

Mumbai - 400 001

Mumbai - 400 051

Scrip Code: 500680

Scrip Symbol: PFIZER

Dear Sirs,

Sub: Audited financial results and Audit Report for the financial year ended March 31, 2024

- Outcome of Board Meeting.

Ref.: Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Audited financial results for the financial year ended March 31, 2024, Statement of Assets and Liabilities as on March 31, 2024, Statement of Audited Cash Flows for the year ended March 31, 2024, Declaration with respect to Audit Report with unmodified opinion and the Auditor's Report by our Statutory Auditors, M/s. B S R & Co., LLP.

The Audited financial results for the year ended March 31, 2024 were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 3:00 p.m. and concluded at 7.15 p.m.

Further, please be informed that the Board of Directors has at its Meeting held today, i.e., May 17, 2024, recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the financial year ended March 31, 2024. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 6, 2024.

Request you to please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

PRAJEET NAIR

Prajeet Nair

Digitally signed by

PRAJEET NAIR Date: 2024.05.17 19:25:27 +05'30'

Director - Corporate Services & Company Secretary

Cc: National Securities Depository Limited (NSDL)

Central Depository Services (India) Limited (CDSL)

KFin Technologies Limited

CIN: L24231MH1950PLC008311

Email ID: contactus.india@pfizer.com

Website: www.pfizerltd.co.in

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Pfizer Ltd. published this content on 18 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 May 2024 08:15:03 UTC.